Róka L, Isert D
Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(6):735-49.
Heparin added to citrated platelet rich plasma influences shape change and aggregation of platelets in different ways. In the presence of heparin neither ADP nor collagen induces shape change, while shape change after thrombin or arachidonic acid remains unaltered. Heparin potentiates the first aggregation step induced by ADP and epinephrine but inhibits aggregation induced by thrombin and ristocetin. The second phase of aggregation and the release reaction are not directly influenced by heparin no matter which aggregation agent is used.
添加到枸橼酸化富血小板血浆中的肝素对血小板的形态变化和聚集有不同影响。在有肝素存在的情况下,ADP和胶原均不诱导形态变化,而凝血酶或花生四烯酸诱导后的形态变化保持不变。肝素增强ADP和肾上腺素诱导的初始聚集步骤,但抑制凝血酶和瑞斯托菌素诱导的聚集。无论使用哪种聚集剂,聚集的第二阶段和释放反应均不受肝素的直接影响。